#MondayTip
Post Stroke #Seizure and #Epilepsy
🧠Cerebrovascular disease is one of the most common causes of epilepsy in adults
☝️There are several risk factors related to development of PSE: localization, seizure onset (early vs #late), etc
Check this PSE Risk Scale👇
#EpilepsyDay Art: It is Not Just a Medical Disorder But a Social Problem by Ruby Kasana (India)
"Do not let myths & misconceptions about #epilepsy make you anxious. If you come across information from any source that makes you uncomfortable, seek the advice of a neurologist..."
#NeuroGyaan - 1
Indications of Endovascular management in #CVT
▶︎Deterioration despite anticoagulation
▶︎Comatose presentation
▶︎Major C/I to anticoagulation (Bleeding disorders, PC <100k, recent GI bleed)
Comment if you encountered more▼
#MondayTip
Stroke & Heart Failure
☝️Up to 20% of pts w/MI &⬇️EF have a LV thrombus
☝️Do not relay only on TTE for dx LVT➡️use🫀MRI
☝️High recurrence! use S2I2N0-3
🧠HFrEF/noAF: anticoagulation⬇️43% stroke/⬆️2x major 🩸
☝️In LVT➡️DOAC better than VKAs
From @SposatoL at #WSC2022
An alternative antiplatelet regimen for TIA/minor stroke population is ASA + Ticagrelor for 30d (🇨🇦,🇺🇸, Euro guidelines below)
Consider in patients with high chance of plavix resistance (CYP2C19 loss of function allele)
~15% Caucasions
~30% Middle East, Africa
~60% East Asia
New path to diagnose vascular parkinsonism proposed by @AlbertoEspay@ParkinsonismD 'Let's restrict VP to neuro outcome of ischemic/hemorrhagic strokes affecting nigra or nigrostriatal path. For others, something missing, left for an attentive clinician to uncover.' @MedscapeLIVE
How to risk stratify TIAs.
WHAT an event was and WHY is happened are more important than a score 💯
➡️ Likely reason why some patients benefit more from DAPT (than single antiplatelet)
https://t.co/wbwbq1WckU
#neurotwitter#stroke